Results 261 to 270 of about 7,373,821 (305)
Some of the next articles are maybe not open access.
Journal of Chronic Diseases, 1962
The Billary System. By W. Taylor, BSc, PhD. Price, $25. Pp 736, with 291 illustrations. F. A. Davis Co., 1914 Cherry St., Philadelphia, Pa 19013, 1965. By J. Vandenbroucke, J. De Groote, and L. O. Standaert. Price, $22. Pp 391, with 165 figures & 72 tables. Williams & Wilkins Co., 428 E Preston St, Baltimore, Md 21202, 1965.
openaire +1 more source
The Billary System. By W. Taylor, BSc, PhD. Price, $25. Pp 736, with 291 illustrations. F. A. Davis Co., 1914 Cherry St., Philadelphia, Pa 19013, 1965. By J. Vandenbroucke, J. De Groote, and L. O. Standaert. Price, $22. Pp 391, with 165 figures & 72 tables. Williams & Wilkins Co., 428 E Preston St, Baltimore, Md 21202, 1965.
openaire +1 more source
Measurement of disease progression in Alzheimer's disease
Neurobiology of Aging, 1988Riege and Metter's comprehensive review deals with many issues pertaining to Alzheimer's disease research. We agree with the authors that early diagnosis and evaluation of disease progression represent key points that must be addressed in an integrated manner. Brain imaging holds great promise for the resolution of both issues.
R P, Friedland, B, Horwitz, E, Koss
openaire +2 more sources
Progress in Parkinson’s disease
European Journal of Neurology, 2003The past few years have seen important advances in our understanding of the causes of Parkinson’s disease (PD) and in our ability to optimize the symptomatic management of the motor features that characterize this disorder. This supplement reviews progress in several important areas of PD and encompasses some of the basic science that underlies current
openaire +2 more sources
Gastroesophageal reflux disease is a progressive disease
Digestive and Liver Disease, 2007It is controversial whether gastrooesophageal reflux disease represents a spectrum disease from a nonerosive to a complicated one, or whether it is a categorial disease, i.e. it can be divided into three categories, such as nonerosive gastrooesophageal reflux disease, erosive gastrooesophageal reflux disease and Barrett's esophagus (BE) with little or ...
F. Pace, S. Pallotta, N. Vakil
openaire +3 more sources
Progress in Parkinson's Disease
New England Journal of Medicine, 1984Over the past few years important advances have taken place in the study of Parkinson's disease.
openaire +2 more sources
Progression in Parkinson's Disease
Cold Spring Harbor Perspectives in MedicineParkinson's disease (PD) is a common neurodegenerative disorder characterized by relentlessly progressive motor and nonmotor clinical features. In this paper, we offer a comprehensive overview of progression in PD, covering the heterogeneous symptomatology crucial for monitoring progression from clinical, pathological, and biomarker perspectives.
Krithi, Irmady, Serge, Przedborski
openaire +2 more sources
Progressive Shrinkage of Involved Arteries in Parallel with Disease Progression in Moyamoya Disease
World Neurosurgery, 2019Recent three-dimensional constructive interference in steady state (3D-CISS) studies have shown that the involved arteries decrease not only their own luminal caliber but also outer diameter in moyamoya disease (MMD). This study was aimed to clarify how the outer diameter of the involved arteries serially change during disease progression in MMD using ...
Shusuke Yamamoto +5 more
openaire +2 more sources
Rate of Progression of Alzheimer's Disease
Journal of the American Geriatrics Society, 1989We determined rate of cognitive decline in 54 patients with a clinical diagnosis of Alzheimer's disease. Cognitive ability was assessed by score on the Blessed test of orientation, memory, and concentration. Rate of progression was defined as the change in score on the Blessed test per year and was computed using a linear regression analysis.
E, Ortof, H A, Crystal
openaire +2 more sources
The progression of Parkinson disease
Neurology, 2007Recent neuropathologic studies suggest that Parkinson disease (PD) does not begin in the substantia nigra compacta (SNc) but only involves this region later in the course of the disease. It is proposed that once the SNc is affected by the original pathobiological process (for example, protein aggregation), additional processes more specific to ...
openaire +2 more sources
Progressive patterns in breast diseases
Medical Hypotheses, 1980Abstract The progressive increase of cyclic nucleotide values from normal breast tissue to benign disease to cancer suggests a natural progression of breast diseases. A promotional role for caffeine and other methylxanthines on fibrocystic breast disease in predisposed women, which has been established, coupled with epidemiological studies which ...
M K, Foecking +2 more
openaire +2 more sources